Skip to main content

Table 1 Percent apoptotic cells as measured by Caspase-3 activity in cells treated with gemcitabine

From: Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer

  % apoptotic cells
  Gemcitabine (ng/ml)
  0 10 25
UK Pan-1/Control 0.38 0.97 3.14
UK Pan-1/shSTAT3.cl.8 3.1 24.4 35.6
PANC-1/Control 0.01 0.01 .02
PANC-1/shSTAT3.cl.22 4.7 6.0 55.4
MIA PaCa-2/Control 0.06 0.06 0.07
MIA PaCa-2/shSTAT3.cl.2 2.6 5.5 10.0
BxPC3/Control 0.04 0.17 0.12
BxPC3/shSTAT3.cl.21 0.4 1.6 5.7